Anthem Biosciences Limited (ANTHEM) — Financial Results

Anthem Biosciences clarified that its FY2026 PAT of ₹5,917.92 million matches the XBRL filing, correcting a prior discrepancy, and will promptly revise the XBRL to include consolidated EPS after an inadvertent clerical omission.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ANTHEM ✨ Ask AI About This

About Anthem Biosciences Limited (ANTHEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹43,999.05 Cr P/E: 109.4

View full ANTHEM stock details →

📡 Get AI alerts when ANTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANTHEM — Free

💡 Ask AI about this filing

"How does this financial results affect Anthem Biosciences Limited's outlook?" "What did Anthem Biosciences Limited announce on 2 July 2026?" "Is this positive or negative for ANTHEM?"

Ask AI Free →

📊 More ANTHEM filings

See all ANTHEM filings →

🔥 Also filed on 2 July 2026

RAJRATAN Rajratan Global Wire Limited Annual Report RAJRATAN Rajratan Global Wire Limited Annual Report PSB Punjab & Sind Bank Annual Report PWL Physicswallah Limited Announcement PSB Punjab & Sind Bank Corporate Action RPGLIFE RPG Life Sciences Limited Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ANTHEM files new disclosures

Track ANTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANTHEM — Free

Free account · 2 AI queries/day